Session: OS2b-A
Personalized therapies

Chair

Prof. Anne-Marie Caminade

Time

15:15 - 16:35 on Tuesday, 26th of June 2018

Venue

Amphitheater

15:15

Measurements of Heterotypic Associations Between Cluster of Differentiation CD74 and CD44 in Human Breast Cancer-Derived Cells

Hussain Alssadh (University of Essex), Patrick Spencer (University of Essex), Waleed Al abdulmonem (Qassim University), Rana Alghamdi (University of Essex), Inamul Hassan (Bharathidasan University), Jose M. Miranda-sayago (University of Essex), Neslon Fernández (University of Essex)
15:35

Precision Medicine and immunomodulatory therapy for Stevens Johnson Syndrome/Toxic Epidermal Necrolysis

Omer Iqbal (Loyola University Medical Center)
15:55

Applications of artificial intelligence in precision medicine

Michal Madera (Rzeszow University of Technology), Jacek Kluska (Rzeszow University of Technology)
16:15

CDA status predicts life-threatening toxicities in AML patients treated with cytarabine

raphaelle fanciullino (Assistance Publique Hôpitaux de Marseille), Laure Flahault (Assistance Publique Hôpitaux de Marseille), Melanie Donnette (Aix Marseille Univ), Diane-charlotte Imbs (Aix Marseille Univ), Vadim Ivanov (Assistance Publique Hôpitaux de Marseille), Geoffroy Venton (Assistance Publique Hôpitaux de Marseille), Ciccolini Joseph (Aix Marseille Univ), L'houcine Ouafik (Assistance Publique Hôpitaux de Marseille), Bruno Lacarelle (laboratory of pharmacokinetics - La Timone), Regis Costello (Assistance Publique Hôpitaux de Marseille)